22 results on '"Hussein, Mohamad"'
Search Results
2. A phase II trial of BAY 43‐9006 (sorafenib) ( NSC ‐724772) in patients with relapsing and resistant multiple myeloma: SWOG S0434
3. Mature results of MM-011: A phase I/II trial of liposomal doxorubicin, vincristine, dexamethasone, and lenalidomide combination therapy followed by lenalidomide maintenance for relapsed/refractory multiple myeloma
4. Phase II study of pegylated liposomal doxorubicin, low-dose dexamethasone, and lenalidomide in patients with newly diagnosed multiple myeloma
5. A review of the history, properties, and use of the immunomodulatory compound lenalidomide
6. An association between renal cell carcinoma and multiple myeloma: a case series and clinical implications
7. Does low‐dose aspirin have antineoplastic effects in multiple myeloma?
8. Uncommon Presentations of Plasma Cell Dyscrasias
9. Pegylated liposomal doxorubicin, vincristine, and dexamethasone provide significant reduction in toxicity compared with doxorubicin, vincristine, and dexamethasone in patients with newly diagnosed multiple myeloma
10. Author reply
11. Monoclonal gammopathy of undetermined significance and multiple myeloma are associated with an increased incidence of venothromboembolic disease
12. Phase 2 study of arsenic trioxide in patients with relapsed or refractory multiple myeloma
13. Prevalence of vitamin B12 deficiency in patients with plasma cell dyscrasias
14. Modifications to Therapy for Multiple Myeloma: Pegylated Liposomal Doxorubicin in Combination With Vincristine, Reduced‐Dose Dexamethasone, and Thalidomide
15. Acquired Activated Protein C Resistance in Myeloma Patients with Venous Thromboembolic Events
16. Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma
17. A new staging system for multiple myeloma patients based on the Southwest Oncology Group (SWOG) experience
18. A Phase I–II trial of polyethylene glycol‐conjugated L‐asparaginase in patients with multiple myeloma
19. The development of novel targeted therapeutics for treatment of multiple myeloma research roundtable
20. Prognostic significance of CD38 and CD20 expression as assessed by quantitative flow cytometry in chronic lymphocytic leukaemia
21. A Phase II trial of pegylated liposomal doxorubicin, vincristine, and reduced‐dose dexamethasone combination therapy in newly diagnosed multiple myeloma patients
22. Modulation of Idiotypic and Antiidiotypic Immunoglobulin G Responses in an Alloimmune Thrombocytopenic Patient Associated with Extracorporeal Protein A Immunoadsorption
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.